Market Cap 159.39M
Revenue (ttm) 16.15M
Net Income (ttm) -77.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -478.82%
Debt to Equity Ratio 0.00
Volume 1,077,900
Avg Vol 617,286
Day's Range N/A - N/A
Shares Out 62.02M
Stochastic %K 98%
Beta 1.33
Analysts Strong Sell
Price Target $6.00

Company Profile

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunoglobulin G1 (IgG1), which is in Phase 1 clinical trial to treat patients with relapsed or refractory solid tumors; and lead immuno-oncology (IO) product candidate is PYX-106, an investigational fully human IgG1 Siglec-15-targeting antibody that is in Phase 1 cl...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 453 3596
Address:
321 Harrison Avenue, 11th Floor, Suite 1, Boston, United States
StockScanners
StockScanners Oct. 4 at 3:10 PM
$PYXS keep watch if this holds above 2.36
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 4 at 11:45 AM
$RADX Do your due diligence https://scr.zacks.com/news/news-details/2025/RADX-RAD101-Imaging-Recurring-Brain-Metastases-article/default.aspx $PYXS $IMNM $ADCT $INMB
0 · Reply
Bullbear1010101
Bullbear1010101 Oct. 3 at 8:55 PM
$PYXS 2.58..
0 · Reply
MLBiotechAnalyst
MLBiotechAnalyst Oct. 3 at 8:44 PM
$PYXS UCBs acquisition of Merus (Pyxis’ later stage competitor in head and neck) this week for $7.1 billion is a pretty good indicator of value.
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 8:34 PM
$PYXS can also say i called it here too <3 love profitable weeks
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 8:33 PM
im just going to start sharing this for my own “trade diary” WEEK OF 9/29/2025 $NKE - great earnings play (0.055 > .12-.16 $80 call 10/3) $PYXS - holding 2.5$ 10/17 calls with an average of .05 (secured 25% of lot at 250%) $TLRY held over last weekend for trump’s cannabinoid truth post; 1.5$ 10/3 calls (.06 > .12-.16)
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 3:19 PM
$PYXS retest to pop :)
0 · Reply
Bullbear1010101
Bullbear1010101 Oct. 3 at 2:16 PM
$PYXS Sold small loss after 1 yr hold
1 · Reply
MrGreenScreen
MrGreenScreen Oct. 3 at 2:13 PM
$PYXS saw some interesting buys yesterday looks bullish
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Oct. 3 at 1:58 PM
0 · Reply
Latest News on PYXS
Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns

Nov 21, 2024, 9:18 AM EST - 11 months ago

Pyxis Oncology's Cancer Drug Progress Stirs Analyst Concerns


Moment Of Truth Approaches For Pyxis Oncology

Sep 13, 2024, 7:08 AM EDT - 1 year ago

Moment Of Truth Approaches For Pyxis Oncology


Pyxis Oncology Successfully Completes Acquisition of Apexigen

Aug 23, 2023, 8:35 AM EDT - 2 years ago

Pyxis Oncology Successfully Completes Acquisition of Apexigen


Pyxis: Unique ADC Approach With A Catalyst In Late 2023

Jun 15, 2023, 8:20 AM EDT - 2 years ago

Pyxis: Unique ADC Approach With A Catalyst In Late 2023


Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs

May 30, 2023, 8:30 AM EDT - 2 years ago

Pyxis Oncology Advances PYX-106 and PYX-201 Clinical Programs


Pyxis Oncology to Acquire Apexigen

May 24, 2023, 6:45 AM EDT - 2 years ago

Pyxis Oncology to Acquire Apexigen


Pyxis Oncology: Cashed Up And Entering The Clinic

Mar 27, 2023, 7:32 AM EDT - 2 years ago

Pyxis Oncology: Cashed Up And Entering The Clinic


StockScanners
StockScanners Oct. 4 at 3:10 PM
$PYXS keep watch if this holds above 2.36
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 4 at 11:45 AM
$RADX Do your due diligence https://scr.zacks.com/news/news-details/2025/RADX-RAD101-Imaging-Recurring-Brain-Metastases-article/default.aspx $PYXS $IMNM $ADCT $INMB
0 · Reply
Bullbear1010101
Bullbear1010101 Oct. 3 at 8:55 PM
$PYXS 2.58..
0 · Reply
MLBiotechAnalyst
MLBiotechAnalyst Oct. 3 at 8:44 PM
$PYXS UCBs acquisition of Merus (Pyxis’ later stage competitor in head and neck) this week for $7.1 billion is a pretty good indicator of value.
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 8:34 PM
$PYXS can also say i called it here too <3 love profitable weeks
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 8:33 PM
im just going to start sharing this for my own “trade diary” WEEK OF 9/29/2025 $NKE - great earnings play (0.055 > .12-.16 $80 call 10/3) $PYXS - holding 2.5$ 10/17 calls with an average of .05 (secured 25% of lot at 250%) $TLRY held over last weekend for trump’s cannabinoid truth post; 1.5$ 10/3 calls (.06 > .12-.16)
0 · Reply
stocksrtoohard
stocksrtoohard Oct. 3 at 3:19 PM
$PYXS retest to pop :)
0 · Reply
Bullbear1010101
Bullbear1010101 Oct. 3 at 2:16 PM
$PYXS Sold small loss after 1 yr hold
1 · Reply
MrGreenScreen
MrGreenScreen Oct. 3 at 2:13 PM
$PYXS saw some interesting buys yesterday looks bullish
0 · Reply
MasterOfMyDomains
MasterOfMyDomains Oct. 3 at 1:58 PM
0 · Reply
biohuntress
biohuntress Oct. 1 at 10:57 PM
$PYXS CEO said updated poster at ESMO ... should be published online via the ESMO website at 00:05 CEST on Monday, 13 October 2025.
2 · Reply
Bullbear1010101
Bullbear1010101 Oct. 1 at 5:06 PM
$PYXS barely volume . next news which rarely is ”news” Gugenheim
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 1 at 2:49 PM
$RADX $PYXS $IMNM $SMMT Trading at 50% discount to last strategic investment from Lantheus
1 · Reply
highnihilism
highnihilism Oct. 1 at 9:45 AM
$DDM ProShares Ultra Dow30 Trade Count: 17 | Total $: 7.1 K | 0.64 × 90-Day Avg $: 11.1 K | Call $: 2.7 K | Put $: 4.4 K | % Single-Leg: 91% | % Multi-Leg: 9% | % Contingent: – $DRN Direxion Daily Real Estate Bull 3X Trade Count: 361 | Total $: 15.6 K | 0.47 × 90-Day Avg $: 33 K | Call $: 2.7 K | Put $: 13 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $EMBC Embecta Corp. Trade Count: 10 | Total $: 3 K | 0.51 × 90-Day Avg $: 5.8 K | Call $: 2.7 K | Put $: 320 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PYXS Pyxis Oncology Trade Count: 23 | Total $: 2.7 K | 0.48 × 90-Day Avg $: 5.6 K | Call $: 2.7 K | Put $: 0 | % Single-Leg: 95% | % Multi-Leg: 5% | % Contingent: –
0 · Reply
MrGreenScreen
MrGreenScreen Sep. 29 at 2:18 PM
$PYXS strong here break that 240 and it goes$PYXS
1 · Reply
MasterOfMyDomains
MasterOfMyDomains Sep. 29 at 2:14 PM
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 27 at 8:17 PM
$RADX Radiopharm Theranostics (Nasdaq: RADX) ———-RAD202—— October Data — $7.5 to $15 billion yearly market opportunity per ChatGPT llm. 100,000 to 200,000 patients globally and $75,000 price tag. Nsclc, head & neck and melanoma https://www.oncidiumfoundation.org/wp-content/uploads/2025/04/177Lu-anti-PD-L1-sdAb.pdf Lantheus bought more at $12 in first quarter. Leader in Radiopharma field. Insiders invested heavily past 24 mos $PYXS $IMNM $MNPR
3 · Reply
Bullbear1010101
Bullbear1010101 Sep. 25 at 5:30 PM
$PYXS yep there it goes 2.08
1 · Reply
biohuntress
biohuntress Sep. 23 at 6:41 PM
$PYXS 13g https://ir.pyxisoncology.com/node/8981/html
1 · Reply
Bullbear1010101
Bullbear1010101 Sep. 22 at 4:11 PM
$PYXS dip 2.36 to 2.16?? or its over ??
1 · Reply
stonkgeeker
stonkgeeker Sep. 22 at 11:25 AM
$PYXS good morning.😎
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 19 at 3:54 PM
Webinar Registration - Radiopharm Theranostics Nasdaq: RADX $LNTH $SABS $CRBP $PYXS https://us02web.zoom.us/webinar/register/WN_Kk2s77p3SbK2XaKHym-SXA#/registration
0 · Reply